





Although normally a commensal inhabitant of the human intestinal and gastrointestinal tract, Escherichia coli is the most common urinary tract pathogen, with overgrowth and colonization causing 85% of urinary tract infections.
Cranberry extracts and ᴅ-mannose each independently inhibit one of the two adhesion methods used by E. coli.
Combined in a synergistic and novel formula, D-Mannose SAP addresses both type 1 (FimH) and type P fimbrial-mediated adhesion of E. coli to the urinary tract mucosa.
D-Mannose SAP is specifically intended for the treatment and prevention of E. coli urinary tract infections.